The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases: Evaluation of interventions and personal health-related goals

Valérie A.M. Meijvis; Mette Heringa; Henk Frans Kwint; Niek J. de Wit; Marcel L. Bouvy

doi:10.1016/j.sapharm.2023.04.118

The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases: Evaluation of interventions and personal health-related goals

Valérie A.M. Meijvis^*, Mette Heringa, Henk Frans Kwint, Niek J. de Wit, Marcel L. Bouvy

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

Background: The CombiConsultation is a consultation with the community pharmacist for patients with diabetes, COPD and/or cardiovascular disease (CVD), aligned with the annual or quarterly consultation with the practice nurse (PN) or general practitioner (GP). The consultation is focused on the personal health-related goals of the patient. Objectives: To assess the number and types of personal health-related goals, drug-related problems (DRPs) and interventions identified by pharmacists during a CombiConsultation and to investigate which patients can benefit most from such consultation. Method: Twenty-one Dutch community pharmacies and associated GP practices were included in the CombiConsultation study. CombiConsultations were performed, involving patients with diabetes, COPD and/or (at risk of) CVD. The pharmacists set health-related goals together with the patients and identified DRPs. The number and types of personal health-related goals, DRPs and interventions were analysed. Associations between patient characteristics and the identification of at least one DRP were analysed by multivariate regression analysis. Results: In 834 patients (49% men, mean age: 70 years), 939 DRPs were identified, mostly (potential) side effects (33%), undertreatment (18%) and overtreatment (14%). In 71% of the patients, one or more DRPs were found, with a median of one DRP per patient. Pharmacists proposed 935 recommendations, of which 72% were implemented. DRPs were found more often in patients using a higher number of drugs for chronic conditions. A total of 425 personal health-related goals were set, of which 53% were (partially) attained. Conclusion: The CombiConsultation can be used as a compact health service contributing to safe and effective use of medication for patients with diabetes, COPD and/or (at risk of) CVD, also in patients under 65 or with less than 5 medications in use. The output of the CombiConsultation reflects its characteristics.

Original language	English
Pages (from-to)	1054-1060
Number of pages	7
Journal	Research in Social and Administrative Pharmacy
Volume	19
Issue number	7
DOIs	https://doi.org/10.1016/j.sapharm.2023.04.118
Publication status	Published - Jul 2023

Bibliographical note

Funding Information:
This work was supported by ZonMw GGG-STIP Grant number 848023004 . ZonMw is the Dutch national organisation for health research and healthcare innovation.

Funding Information:
This work was supported by ZonMw GGG-STIP Grant number 848023004. ZonMw is the Dutch national organisation for health research and healthcare innovation.

Publisher Copyright:
© 2023 The Authors

Funding

This work was supported by ZonMw GGG-STIP Grant number 848023004 . ZonMw is the Dutch national organisation for health research and healthcare innovation. This work was supported by ZonMw GGG-STIP Grant number 848023004. ZonMw is the Dutch national organisation for health research and healthcare innovation.

Keywords

CombiConsultation
Community pharmacist
General practice
Pharmaceutical care
Primary care

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.sapharm.2023.04.118Licence: CC BY

1-s2.0-S1551741123002334-mainFinal published version, 783 KBLicence: CC BY

Cite this

@article{88d6bade1e3943c7b9795ae9cbf6506c,

title = "The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases: Evaluation of interventions and personal health-related goals",

abstract = "Background: The CombiConsultation is a consultation with the community pharmacist for patients with diabetes, COPD and/or cardiovascular disease (CVD), aligned with the annual or quarterly consultation with the practice nurse (PN) or general practitioner (GP). The consultation is focused on the personal health-related goals of the patient. Objectives: To assess the number and types of personal health-related goals, drug-related problems (DRPs) and interventions identified by pharmacists during a CombiConsultation and to investigate which patients can benefit most from such consultation. Method: Twenty-one Dutch community pharmacies and associated GP practices were included in the CombiConsultation study. CombiConsultations were performed, involving patients with diabetes, COPD and/or (at risk of) CVD. The pharmacists set health-related goals together with the patients and identified DRPs. The number and types of personal health-related goals, DRPs and interventions were analysed. Associations between patient characteristics and the identification of at least one DRP were analysed by multivariate regression analysis. Results: In 834 patients (49% men, mean age: 70 years), 939 DRPs were identified, mostly (potential) side effects (33%), undertreatment (18%) and overtreatment (14%). In 71% of the patients, one or more DRPs were found, with a median of one DRP per patient. Pharmacists proposed 935 recommendations, of which 72% were implemented. DRPs were found more often in patients using a higher number of drugs for chronic conditions. A total of 425 personal health-related goals were set, of which 53% were (partially) attained. Conclusion: The CombiConsultation can be used as a compact health service contributing to safe and effective use of medication for patients with diabetes, COPD and/or (at risk of) CVD, also in patients under 65 or with less than 5 medications in use. The output of the CombiConsultation reflects its characteristics.",

keywords = "CombiConsultation, Community pharmacist, General practice, Pharmaceutical care, Primary care",

author = "Meijvis, {Val{\'e}rie A.M.} and Mette Heringa and Kwint, {Henk Frans} and {de Wit}, {Niek J.} and Bouvy, {Marcel L.}",

note = "Funding Information: This work was supported by ZonMw GGG-STIP Grant number 848023004 . ZonMw is the Dutch national organisation for health research and healthcare innovation. Funding Information: This work was supported by ZonMw GGG-STIP Grant number 848023004. ZonMw is the Dutch national organisation for health research and healthcare innovation. Publisher Copyright: {\textcopyright} 2023 The Authors",

year = "2023",

month = jul,

doi = "10.1016/j.sapharm.2023.04.118",

language = "English",

volume = "19",

pages = "1054--1060",

journal = "Research in Social and Administrative Pharmacy",

issn = "1551-7411",

publisher = "Elsevier Inc.",

number = "7",

}

The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases: Evaluation of interventions and personal health-related goals. / Meijvis, Valérie A.M.; Heringa, Mette; Kwint, Henk Frans et al.
In: Research in Social and Administrative Pharmacy, Vol. 19, No. 7, 07.2023, p. 1054-1060.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases

T2 - Evaluation of interventions and personal health-related goals

AU - Meijvis, Valérie A.M.

AU - Heringa, Mette

AU - Kwint, Henk Frans

AU - de Wit, Niek J.

AU - Bouvy, Marcel L.

N1 - Funding Information: This work was supported by ZonMw GGG-STIP Grant number 848023004 . ZonMw is the Dutch national organisation for health research and healthcare innovation. Funding Information: This work was supported by ZonMw GGG-STIP Grant number 848023004. ZonMw is the Dutch national organisation for health research and healthcare innovation. Publisher Copyright: © 2023 The Authors

PY - 2023/7

Y1 - 2023/7

N2 - Background: The CombiConsultation is a consultation with the community pharmacist for patients with diabetes, COPD and/or cardiovascular disease (CVD), aligned with the annual or quarterly consultation with the practice nurse (PN) or general practitioner (GP). The consultation is focused on the personal health-related goals of the patient. Objectives: To assess the number and types of personal health-related goals, drug-related problems (DRPs) and interventions identified by pharmacists during a CombiConsultation and to investigate which patients can benefit most from such consultation. Method: Twenty-one Dutch community pharmacies and associated GP practices were included in the CombiConsultation study. CombiConsultations were performed, involving patients with diabetes, COPD and/or (at risk of) CVD. The pharmacists set health-related goals together with the patients and identified DRPs. The number and types of personal health-related goals, DRPs and interventions were analysed. Associations between patient characteristics and the identification of at least one DRP were analysed by multivariate regression analysis. Results: In 834 patients (49% men, mean age: 70 years), 939 DRPs were identified, mostly (potential) side effects (33%), undertreatment (18%) and overtreatment (14%). In 71% of the patients, one or more DRPs were found, with a median of one DRP per patient. Pharmacists proposed 935 recommendations, of which 72% were implemented. DRPs were found more often in patients using a higher number of drugs for chronic conditions. A total of 425 personal health-related goals were set, of which 53% were (partially) attained. Conclusion: The CombiConsultation can be used as a compact health service contributing to safe and effective use of medication for patients with diabetes, COPD and/or (at risk of) CVD, also in patients under 65 or with less than 5 medications in use. The output of the CombiConsultation reflects its characteristics.

AB - Background: The CombiConsultation is a consultation with the community pharmacist for patients with diabetes, COPD and/or cardiovascular disease (CVD), aligned with the annual or quarterly consultation with the practice nurse (PN) or general practitioner (GP). The consultation is focused on the personal health-related goals of the patient. Objectives: To assess the number and types of personal health-related goals, drug-related problems (DRPs) and interventions identified by pharmacists during a CombiConsultation and to investigate which patients can benefit most from such consultation. Method: Twenty-one Dutch community pharmacies and associated GP practices were included in the CombiConsultation study. CombiConsultations were performed, involving patients with diabetes, COPD and/or (at risk of) CVD. The pharmacists set health-related goals together with the patients and identified DRPs. The number and types of personal health-related goals, DRPs and interventions were analysed. Associations between patient characteristics and the identification of at least one DRP were analysed by multivariate regression analysis. Results: In 834 patients (49% men, mean age: 70 years), 939 DRPs were identified, mostly (potential) side effects (33%), undertreatment (18%) and overtreatment (14%). In 71% of the patients, one or more DRPs were found, with a median of one DRP per patient. Pharmacists proposed 935 recommendations, of which 72% were implemented. DRPs were found more often in patients using a higher number of drugs for chronic conditions. A total of 425 personal health-related goals were set, of which 53% were (partially) attained. Conclusion: The CombiConsultation can be used as a compact health service contributing to safe and effective use of medication for patients with diabetes, COPD and/or (at risk of) CVD, also in patients under 65 or with less than 5 medications in use. The output of the CombiConsultation reflects its characteristics.

KW - CombiConsultation

KW - Community pharmacist

KW - General practice

KW - Pharmaceutical care

KW - Primary care

UR - http://www.scopus.com/inward/record.url?scp=85153289863&partnerID=8YFLogxK

U2 - 10.1016/j.sapharm.2023.04.118

DO - 10.1016/j.sapharm.2023.04.118

M3 - Article

AN - SCOPUS:85153289863

SN - 1551-7411

VL - 19

SP - 1054

EP - 1060

JO - Research in Social and Administrative Pharmacy

JF - Research in Social and Administrative Pharmacy

IS - 7

ER -

The CombiConsultation for patients with diabetes, COPD and cardiovascular diseases: Evaluation of interventions and personal health-related goals

Abstract

Bibliographical note

Funding

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this